Comprehensive Screening Reveals Strong and Broadly Directed Human Immunodeficiency Virus Type 1-Specific CD8 Responses in Perinatally Infected Children
- 1 July 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (13) , 7492-7501
- https://doi.org/10.1128/jvi.77.13.7492-7501.2003
Abstract
Advances in antiviral therapy have dramatically shifted the demographics of pediatric human immunodeficiency virus type 1 (HIV-1) infection in the developed world, and a growing proportion of perinatally HIV-1-infected children are now entering their second or even third decade of life. Although cellular immune responses to HIV are known to be weak in early infancy, the magnitude, breadth, and specificity of responses later in childhood have not been characterized in detail. We performed a comprehensive characterization of HIV-1-specific CD8 responses in 18 perinatally infected children (age range, 6 to 17 years), most of whom were on antiviral therapy, using both previously defined HIV-1 epitopes and overlapping peptides spanning all HIV-1 proteins. Multispecific responses were detected in all subjects and accounted for a median of 0.25 to 0.3% of all peripheral blood mononuclear cells that was similar to the magnitude seen in HIV-infected adults. CD8 responses were broadly directed at an average of 11 epitopes (range, 2 to 27 epitopes) and targeted nearly all HIV-1 proteins, with the highest proportion in Gag. Responses were readily detected even in those children with suppressed viremia on highly active antiretroviral therapy, although the breadth ( P = 0.037) and the magnitude ( P = 0.021) were significantly lower in these subjects. Each child recognized only a small minority of the HIV-1 optimal epitopes defined for his or her class I HLA alleles. Together, these data indicate that perinatally infected children who survive infancy mount a robust HIV-1-specific CD8 response that is much stronger than previously thought and is comparable in magnitude and breadth to that of adults. Moreover, this response has the potential to be broadened to target more epitopes, making these children attractive candidates for immunotherapeutic interventions.Keywords
This publication has 45 references indexed in Scilit:
- Frequencies of Ex Vivo-Activated Human Immunodeficiency Virus Type 1-Specific Gamma-Interferon-Producing CD8 + T Cells in Infected Children Correlate Positively with Plasma Viral LoadJournal of Virology, 2002
- Frequency and Phenotyping of Human Immunodeficiency Virus (HIV)–Specific CD8+T Cells in HIV‐Infected Children, Using Major Histocompatibility Complex Class I Peptide TetramersThe Journal of Infectious Diseases, 2001
- Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining AssaysJournal of Virology, 2001
- The Impact of Early Initiation of Highly Active Antiretroviral Therapy on the Human Immunodeficiency Virus Type 1–Specific CD8 T Cell Response in ChildrenThe Journal of Infectious Diseases, 2000
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Age- and Time-related Changes in Extracellular Viral Load in Children Vertically Infected by Human Immunodeficiency VirusThe Pediatric Infectious Disease Journal, 1996
- Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of DefectsScience, 1996
- Induction of T H 1 and T H 2 Immunity in Neonatal MiceScience, 1996
- High Frequency Of Gag- And Envelope-Specific Cytotoxic T Lymphocyte Precursors In Children With Vertically Acquired Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 1994
- Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected childrenThe Journal of Pediatrics, 1991